Mark Faesen
Impact in
- Epidemiology top 10%
- Cervical Cancer and HPV Research
- Hepatitis B Virus Studies
-
- Reproductive tract infections research
Papers in
- Epidemiology 11
- Cervical Cancer and HPV Research 11
- Hepatitis B Virus Studies 1
-
- COVID-19 Clinical Research Studies 1
- SARS-CoV-2 and COVID-19 Research 1
- Co-authors
- Cynthia Firnhaber (9 shared papers)Simon A. Levin (10 shared papers)Jennifer S. Smith (6 shared papers)Sophie Williams (8 shared papers)Pam Michelow (7 shared papers)Avril Swarts (9 shared papers)Anna‐Lise Williamson (5 shared papers)Tanvier Omar (3 shared papers)
- Journals
- PLoS ONE (2 papers)Journal of the International AIDS Society (1 paper)Clinical Infectious Diseases (1 paper)American Journal of Obstetrics and Gynecology (1 paper)Journal of Lower Genital Tract Disease (1 paper)
- Partner nations
- South AfricaUnited StatesIndia
In The Last Decade
Mark Faesen
11 papers receiving 293 citations
Peers
Comparison fields: 5 of 43
- Epidemiology 241
- Microbiology 17
- Infectious Diseases 33
- Oncology 39
- Otorhinolaryngology 6
Countries citing papers authored by Mark Faesen
This map shows the geographic impact of Mark Faesen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Faesen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Faesen more than expected).
Fields of papers citing papers by Mark Faesen
This network shows the impact of papers produced by Mark Faesen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Faesen. The network helps show where Mark Faesen may publish in the future.
Co-authors
The 25 scholars most cited alongside Mark Faesen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2013 | 90 | |
| 2 | 2012 | 50 | |
| 3 | 2017 | 33 | |
| 4 | 2014 | 30 | |
| 5 | 2022 | 27 | |
| 6 | 2016 | 20 | |
| 7 | 2020 | 17 | |
| 8 | 2017 | 10 | |
| 9 | 2016 | 10 | |
| 10 | 2018 | 5 | |
| 11 | 2010 | 2 | |
| 12 | 2018 | 0 |
About Mark Faesen
Mark Faesen is a scholar working on Epidemiology, Infectious Diseases, Modeling and Simulation, Organic Chemistry and Surgery, having authored 12 papers that have together received 294 indexed citations. Recurring topics across this work include Cervical Cancer and HPV Research (11 papers), Hepatitis B Virus Studies (1 paper), COVID-19 Clinical Research Studies (1 paper), SARS-CoV-2 and COVID-19 Research (1 paper) and COVID-19 epidemiological studies (1 paper). The work is most often cited by research in Epidemiology (241 citations), Microbiology (17 citations), Infectious Diseases (33 citations), Oncology (39 citations) and Otorhinolaryngology (6 citations). Mark Faesen has collaborated with scholars based in South Africa, United States and India. Frequent co-authors include Cynthia Firnhaber, Simon A. Levin, Jennifer S. Smith, Sophie Williams, Pam Michelow, Avril Swarts, Anna‐Lise Williamson, Tanvier Omar, Michael G. Hudgens and David A. Lewis. Their work appears in journals such as PLoS ONE, Journal of the International AIDS Society, Clinical Infectious Diseases, American Journal of Obstetrics and Gynecology and Journal of Lower Genital Tract Disease.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.